Pancreatic Cancer Research

ResearcherFirst Affiliated Hospital of Nanchang UniversityNo recent work listed

Zhi Fang

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5087063802. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
12
Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: 2 papers

Papers 3

  1. LINC01128 facilitates the progression of pancreatic cancer through up-regulation of LDHA by targeting miR-561-5p. First author DOI 10.1186/s12935-022-02490-5↗
  2. Silencing LINC00491 Inhibits Pancreatic Cancer Progression through MiR-188-5p-induced Inhibition of ZFP91. Co-author DOI 10.7150/jca.65071↗
  3. A reciprocal feedback of Myc and lncRNA MTSS1-AS contributes to extracellular acidity-promoted metastasis of pancreatic cancer. Co-author DOI 10.7150/thno.49147↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zhiwang Song · 2 shared papers, 2022 · strength 0.37
  2. Jianping Xiong · 2 shared papers, 2022 · strength 0.37
  3. Min Zhong · 2 shared papers, 2022 · strength 0.37
  4. Junhe Li · 1 shared paper, 2022 · strength 0.19
  5. Yanxia Jiang · 1 shared paper, 2022 · strength 0.19
  6. Fengyu Xu · 1 shared paper, 2020 · strength 0.09
  7. Gang Zhao · 1 shared paper, 2020 · strength 0.09
  8. Peng Xu · 1 shared paper, 2020 · strength 0.09
  9. Wei Li · 1 shared paper, 2020 · strength 0.09
  10. Zhu Zeng · 1 shared paper, 2020 · strength 0.09
  11. Yuhang Hu · 1 shared paper, 2020 · strength 0.09
  12. Chunyou Wang · 1 shared paper, 2020 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.